Frontlight ResearchEarly access
Trial site
City of Hope® Cancer Center Chicago
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Metastatic breast cancer2 trials
- Bladder cancer1 trial
- Gastric and oesophageal cancer1 trial
- Mesothelioma1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 32 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Recruiting4 trials
- Lead sponsor
- Hoffmann-La Roche3 trials
- IDEAYA Biosciences1 trial
Running trials
Recruiting
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Bladder cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Mesothelioma1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026